Drugs.com - FDA MedWatch Alerts

Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter

Audience: Consumer, Health Professional, Pharmacy April 18, 2025 -- Bridgewater, NJ, Amneal Pharmaceutical LLC, is recalling two lots of Ropivacaine Hydrochloride Injection, USP, 500mg/100mL, Infusion bags to the hospital/user level as the products...

Apr 21, 2025 - 23:10
 0
Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter
Audience: Consumer, Health Professional, Pharmacy April 18, 2025 -- Bridgewater, NJ, Amneal Pharmaceutical LLC, is recalling two lots of Ropivacaine Hydrochloride Injection, USP, 500mg/100mL, Infusion bags to the hospital/user level as the products...
Read More

Tags:

Previous Article

Biologique Recherche choisit la technologie Squeeze'n Roll de Cosmogen

Next Article

STAT+: NIH director calls Trump’s anti-DEI orders ‘misunderstood,’ downplays reo...

Related Posts

FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize

FDA Clarifies Policies for Compounders as National GLP-...

Feb 9, 2025  0

B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 1000 mL in E3 Containers Due to the Potential for Particulate Matter and Leakage

B. Braun Issues Voluntary Nationwide Recall of 0.9% Sod...

Feb 9, 2025  0

FDA Requires Guillain-Barré Syndrome (GBS) Warning in the Prescribing Information for RSV Vaccines Abrysvo and Arexvy

FDA Requires Guillain-Barré Syndrome (GBS) Warning in t...

Feb 9, 2025  0